TITLE

IL-23R is epigenetically regulated and modulated by chemotherapy in Non-Small Cell Lung Cancer

AUTHOR(S)
Baird, Anne-Marie; Dockry^2,3, √Čilis; Daly, Anne; Stack, Emma; Doherty, Derek G.; O'Byrne, Kenneth J.; Gray, Steven G.
PUB. DATE
June 2013
SOURCE
Frontiers in Oncology;Jun2013, Vol. 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The IL-23/IL-23R signalling axis is an important inflammatory pathway, involved in the stimulation and regulation of the T helper (Th) 17 lymphocytes, resulting in the production of IL-17. Aside from auto-immunity, this cytokine has also been linked to carcinogenesis and polymorphisms in the IL-23R gene are associated with an increased risk for the development of a number of different cancers. Activation of the IL-23 pathway results in the up regulation of STAT3 and it is thought that the pathological consequences associated with this are in part due to the production of IL-17. We have previously identified IL-23A as pro-proliferative and epigenetically regulated in non-small cell lung cancer (NSCLC). The current study aims to evaluate IL-23R in greater detail in NSCLC. We demonstrate that IL-23R is expressed and epigenetically regulated in NSCLC through histone post translation modifications and CpG island methylation. In addition, Gemcitabine treatment, a chemotherapy drug used in the treatment of NSCLC, resulted in the up regulation of the IL-23R. Furthermore, Apilimod (STA 5326), a small molecule which blocks the expression of IL-23 and IL-12, reduced the proliferative capacity of NSCLC cells, particularly in the adenocarcinoma (A549) sub-type. Apilimod is currently undergoing investigation in a number of clinical trials for the treatment of auto-immune conditions such as Crohn's disease and Rheumatoid Arthritis. Our results may have implications for treating NSCLC patients with Gemcitabine or epigenetic targeted therapies. However, Apilimod may possibly provide a new treatment avenue for NSCLC patients. Work is currently ongoing to further delineate the IL-23/IL-23R axis in this disease.
ACCESSION #
88067189

 

Related Articles

  • Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor. Li, Jun; Zhang, Le; Zhang, Jie; Wei, Yuyan; Li, Kai; Huang, Lugang; Zhang, Sen; Gao, Bo; Wang, Xiujie; Lin, Ping // Carcinogenesis;Mar2013, Vol. 34 Issue 3, p658 

    A proinflammatory cytokine, interleukin 23 (IL-23), plays a role in tumor progression by inducing inflammation in the tumor microenvironment, although there is debate about its role in carcinogenesis. Direct effects of IL-23 on tumor cells have been reported rarely, and contradictory effects...

  • NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Ulanovskaya, Olesya A; Zuhl, Andrea M; Cravatt, Benjamin F // Nature Chemical Biology;May2013, Vol. 9 Issue 5, p300 

    Nicotinamide N-methyltransferase (NNMT) is overexpressed in a variety of human cancers, where it contributes to tumorigenesis by a mechanism that is still poorly understood. Here we show using metabolomics that NNMT impairs the methylation potential of cancer cells by consuming methyl units from...

  • Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Kikuchi, Takefumi; Daigo, Yataro; Katagiri, Toyomasa; Tsunoda, Tatsuhiko; Okada, Koichi; Kakiuchi, Soji; Zembutsu, Hitoshi; Furukawa, Yoichi; Kawamura, Masafumi; Kobayashi, Koichi; Imai, Kohzoh; Nakamura, Yusuke // Oncogene;4/10/2003, Vol. 22 Issue 14, p2192 

    To investigate genes involved in pulmonary carcinogenesis and those related to sensitivity of nonsmall cell lung cancers (NSCLCs) to therapeutic drugs, we performed cDNA microarray analysis of 37 NSCLCs after laser-capture microdissection of cancer cells from primary tumors. A clustering...

  • CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. Shmelkov, Sergey V.; Butler, Jason M.; Hooper, Andrea T.; Hormigo, Adilia; Kushner, Jared; Milde, Till; St. Clair, Ryan; Baljevic, Muhamed; White, Ian; Jin, David K.; Chadburn, Amy; Murphy, Andrew J.; Valenzuela, David M.; Gale, Nicholas W.; Thurston, Gavin; Yancopoulos, George D.; D'Angelica, Michael; Kemeny, Nancy; Lyden, David; Rafii, Shahin // Journal of Clinical Investigation;Jun2008, Vol. 118 Issue 6, p2111 

    Colon cancer stem cells are believed to originate from a rare population of putative CD133+ intestinal stem cells. Recent publications suggest that a small subset of colon cancer cells expresses CD133, and that only these CD133+ cancer cells are capable of tumor initiation. However, the precise...

  • Histone Modifications Are Associated with Transcript Isoform Diversity in Normal and Cancer Cells. Podlaha, Ondrej; De, Subhajyoti; Gonen, Mithat; Michor, Franziska // PLoS Computational Biology;Jun2014, Vol. 10 Issue 6, p1 

    Mechanisms that generate transcript diversity are of fundamental importance in eukaryotes. Although a large fraction of human protein-coding genes and lincRNAs produce more than one mRNA isoform each, the regulation of this phenomenon is still incompletely understood. Much progress has been made...

  • The Role of Sulforaphane in Epigenetic Mechanisms, Including Interdependence between Histone Modification and DNA Methylation. Kaufman-Szymczyk, Agnieszka; Majewski, Grzegorz; Lubecka-Pietruszewska, Katarzyna; Fabianowska-Majewska, Krystyna // International Journal of Molecular Sciences;2015, Vol. 16 Issue 12, p29732 

    Carcinogenesis as well as cancer progression result from genetic and epigenetic changes of the genome that leads to dysregulation of transcriptional activity of genes. Epigenetic mechanisms in cancer cells comprise (i) post-translation histone modification (i.e., deacetylation and methylation);...

  • ATRA Inhibits the Proliferation of DU145 Prostate Cancer Cells through Reducing the Methylation Level of HOXB13 Gene. Zhiwei Liu; Guoling Ren; Chenyan Shangguan; Lijing Guo; Zhixiong Dong; Yueyang Li; Weina Zhang; Li Zhao; Pingfu Hou; Yu Zhang; Xiuli Wang; Jun Lu; Baiqu Huang // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    All-trans retinoic acid (ATRA) has been widely investigated for treatments of many cancers including prostate cancer. HOXB13, silenced in androgen receptor-negative (AR-) prostate cancer cells, plays a role in AR2 prostate cancer cell growth arrest. In this study we intended to elucidate the...

  • Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation. Morrison, P J; Bending, D; Fouser, L A; Wright, J F; Stockinger, B; Cooke, A; Kullberg, M C // Mucosal Immunology (1933-0219);Nov2013, Vol. 6 Issue 6, p1143 

    Bacterial-induced intestinal inflammation is crucially dependent on interleukin (IL)-23 and is associated with CD4+ T helper type 1 (Th1) and Th17 responses. However, the relative contributions of these subsets during the induction and resolution of colitis in T-cell-sufficient hosts remain...

  • Genomic insights into cancer-associated aberrant CpG island hypermethylation. Sproul, Duncan; Meehan, Richard R. // Briefings in Functional Genomics;May2013, Vol. 12 Issue 3, p174 

    Carcinogenesis is thought to occur through a combination of mutational and epimutational events that disrupt key pathways regulating cellular growth and division. The DNA methylomes of cancer cells can exhibit two striking differences from normal cells; a global reduction of DNA methylation...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics